Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Guardian Pharmacy Services, Inc. Class A Common Stock
(NY:
GRDN
)
30.09
-0.17 (-0.56%)
Official Closing Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardian Pharmacy Services, Inc. Class A Common Stock
< Previous
1
2
Next >
Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Earnings Scheduled For March 26, 2025
↗
March 26, 2025
Via
Benzinga
Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results; Provides 2025 Financial Guidance and Earnings Conference Call Date
March 03, 2025
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
February 17, 2025
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy
December 17, 2024
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
December 03, 2024
Via
Benzinga
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
December 02, 2024
Via
Benzinga
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 19, 2024
Via
Benzinga
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
October 31, 2024
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
October 30, 2024
From
Guardian Pharmacy Services, Inc.
Via
Business Wire
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
↗
October 21, 2024
Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market.
Via
Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 21, 2024
Via
Benzinga
Self-Driving Startup Pony.ai Files For U.S. IPO
↗
October 20, 2024
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group...
Via
Talk Markets
Topics
Initial Public Offering
Obesity Drug Developer BioAge Makes Nasdaq Debut
↗
September 29, 2024
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
Via
Talk Markets
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today